Administration of FGF2 for treamtent of anxiety

US8415298B2 · kind B2 · utility

Assignee

• The Board of Trustees of the Leland Stanford Junior University of Stanford · US

Inventors

• Huda Akil · Ann Arbor, US
• William Bunney · Laguna Beach, US
• Prabhakara V. Choudary · Davis, US
• Simon J. Evans · Milan, US
• Edward G. Jones · Winters, US
• Jun Li · Palo Alto, US
• Juan F. Lopez · Ann Arbor, US
• David M. Lyons · Palo Alto, US
• Margherita Molnar · Davis, US
• Richard M. Myers · Huntsville, US
• Alan F. Schatzberg · Los Altos, US
• Richard Stein · Denver, US
• Robert C. Thompson · Boulder, US
• Hiroaki Tomita · Kyoto, JP
• Marquis Vawter · Watsonville, US
• Stanley Watson · Ann Arbor, US

Key dates

• Filing date: Jun 21, 2005
• Grant date: Apr 9, 2013
• Expiry date: Aug 10, 2026

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2800/304
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides methods for diagnosing mental disorders. The invention also provides methods of identifying modulators of mental disorders as well as methods of using these modulators to treat patients suffering from mental disorders.